Galectin-9, a player in cytokine release syndrome and a surrogate diagnostic biomarker in SARS-coV-2 infection
Food and Drug Administration determined earlier this year that the shortage had ended
L., et al., Vildagliptin, a Dipeptidyl PeptidaseIV Inhibitor, Improves ModelAssessed Cell Function in Patients With Type 2 Diabetes, Journal of Clinical Endocrinology and Metabolism 90, no
The MMDR review process and methodology are described in detail on the Australian Government Department of Health (DoH) and TGA websites [4, 5]
Cuts of this magnitude would decimate the program, reducing the size of the annual allocation by more than half, the letter states
This regulatory clarity makes it easier for patients to distinguish between legitimate medical therapy and the gray market of research chemicals